Wells Fargo & Company Issues Pessimistic Forecast for Healthpeak Properties (NYSE:DOC) Stock Price

Healthpeak Properties (NYSE:DOC) had its price objective reduced by stock analysts at Wells Fargo & Company from $23.00 to $22.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 3.53% from the company’s current price.

A number of other analysts also recently weighed in on DOC. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and upped their target price for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Robert W. Baird upped their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Scotiabank upped their target price on shares of Healthpeak Properties from $23.00 to $24.00 and gave the stock a “sector outperform” rating in a research report on Monday, September 9th. Finally, Royal Bank of Canada increased their price objective on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $22.93.

Healthpeak Properties Stock Down 0.9 %

Shares of Healthpeak Properties stock opened at $21.25 on Tuesday. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. The company’s fifty day simple moving average is $22.00 and its two-hundred day simple moving average is $21.34. The company has a market cap of $14.86 billion, a P/E ratio of 45.21, a PEG ratio of 2.38 and a beta of 1.13. Healthpeak Properties has a 12-month low of $16.01 and a 12-month high of $23.26.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million during the quarter, compared to analysts’ expectations of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The firm’s quarterly revenue was up 25.9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.45 earnings per share. Research analysts anticipate that Healthpeak Properties will post 1.8 EPS for the current year.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently bought and sold shares of DOC. HM Payson & Co. bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $25,000. S.A. Mason LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $26,000. Rise Advisors LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $29,000. Fortitude Family Office LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $32,000. Finally, Barrett & Company Inc. bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $33,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.